Le Lézard
Classified in: Health
Subjects: LAW, AVO

Law Offices of Leah V. Durant Speak Out against Proposed Change to U.S. Vaccine Policy


WASHINGTON, April 2, 2020 /PRNewswire/ -- Today, the Law Offices of Leah V. Durant PLLC applauded a newly released open letter to Health and Human Services Secretary Alex Azar from noted orthopedic surgeon Uma Srikumaran, that criticizes a proposed rule that would remove Shoulder Injury Related to Vaccine Administration from the list of injuries covered by the National Vaccine Injury Compensation Program.

"The federal government has long acknowledged that routine vaccines, including the annual flu shot, can cause severe shoulder injuries in rare cases," said Leah Durant, principal at the Law Offices of Leah V. Durant PLLC. "Preventing those who have been injured by vaccines from seeking the compensation they're entitled to could discourage people from getting vaccinated -- to the detriment of public health."

Congress created the National Vaccine Injury Compensation Program to compensate individuals for certain vaccine-related injuries. Shoulder Injury Related to Vaccine Administration, or SIRVA, was added to the list of eligible injuries in 2017. SIRVA can result in rotator cuff tears, bursitis, tendinitis, paresthesia, and other symptoms that can require painful surgeries or other invasive therapies.

In February, the Department of Health and Human Services unveiled a proposed rule to prevent people who have suffered SIRVA from seeking compensation. It's the first time federal officials have proposed removing an injury from the Vaccine Program. Today, SIRVA accounts for more than half of all claims filed. In the past decade, thousands of people have received compensation for shoulder injuries.

Dr. Srikumaran, who heads the Shoulder Fellowship program at Johns Hopkins, argues that the proposed rule could drive up the cost of delivering vaccines and reduce the number of people willing to administer them.

"The program was created specifically to overcome the limitations and difficulties of civil litigation as well as the ramification of increased litigation against pharmaceutical companies," Srikumaran wrote in his letter to Azar. "Considering the current COVID pandemic crisis, shifting the risk to private providers and pharmaceutical companies does not seem to be a reasonable proposal."

For more information or to speak with a representative of The Law Offices of Leah V. Durant PLLC, please contact Micah Ezekiel at 202-471-4228 ext. 118 or [email protected].

About the Law Offices of Leah V. Durant PLLC
Founded by a SIRVA survivor, the Law Offices of Leah V. Durant PLLC has been successful in helping hundreds of individuals obtain financial compensation for cases of SIRVA linked to vaccines. To learn more about how to combat this proposed rule, contact the Law Offices of Leah V. Durant PLLC, or visit our website today: www.vaccinelaw.com.

SOURCE Law Offices of Leah V. Durant PLLC


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: